COVID Vaccine: Nigeria to Recieve 41 Million Doses in September
-
Nigeria is set to receive over 41 million doses of COVID vaccine before the end of September 2021 according to National Primary Health Care Development Agency (NPHCDA) Director, Faisal Shuaib
-
The vaccines being expected will comprise of various brands including Pfizer-Bio-N Tech, AstraZeneca and Johnson & Johnson
-
11,432,770 COVID vaccine doses are expected from the COVAX facility, while 29,850,000 doses of Johnson & Johnson will be gotten from the African Union Commission
The Federal Government has disclosed that Nigeria is set to receive 41,282,770 doses of COVID vaccine before the end of September 2021.
While speaking at a briefing on Tuesday, the Executive Director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib stated that the expected doses of vaccine will be a combination of AstraZeneca vaccines, Pfizer, and Johnson & Johnson (J&J) vaccine.
While the AstraZeneca and Pfizer doses are set to be received through WHO’s COVAX initiative, the J&J vaccines are expected from the African Union Commission.
The first batch of COVID vaccines (3,924,000 doses of AstraZeneca/Moderna) will be received by the end of July or the beginning of August according to Mr Shuaib.
3,930,910 doses of Pfizer/Moderna will then be received in August as a donation from the United States government, along with 3,577,860 doses of Pfizer from the COVAX facility.
The final 29,850,000 doses of the Johnson & Johnson COVID vaccine will be received by the end of September.
Read also: Nigeria to Receive Help From Cuba for Vaccine Production
The NPHCDA boss added that the government is setting up plans for the storage and distribution of the vaccine.
Currently, only 4 million doses of vaccines have been delivered to Nigeria and the government had revealed that the batch is close to being exhausted.
Follow Naija.fm on our social media handles Facebook, Instagram, and Twitter to keep up with trending news, breaking news, entertainment news, and hot gist.
